Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;29(1):66-72.
doi: 10.1038/jcbfm.2008.88. Epub 2008 Jul 23.

The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic

Takato Abe  1 , Alexander Kunz, Munehisa Shimamura, Ping Zhou, Josef Anrather, Costantino Iadecola
Affiliations

The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic

Takato Abe et al. J Cereb Blood Flow Metab. 2009 Jan.

Abstract

We investigated the preclinical characteristics of the neuroprotective effect of the prostaglandin E2 type 1 receptor (EP1) antagonist SC51089 in models of focal cerebral ischemia produced by occlusion of the mouse middle cerebral artery (MCA). We found that systemic administration of SC51089 (5 to 20 microg/kg; i.p.) reduces the brain injury produced by transient (-50%+/-8%; n=12; P<0.05) or permanent (-39%+/-7%; n=12; P<0.05) MCA occlusion. SC51089 was effective even when administered up to 12 h after ischemia. The protective effect was observed both in male and female mice and was sustained for at least 2 weeks after induction of ischemia. The reduction in injury volume was associated with an improvement in neurological function assessed by the Bederson deficit score, the hanging wire test and the corner test. The data provide proof of principle that EP1 receptor inhibition is a potentially valuable strategy for neuroprotection that deserves further preclinical investigation for therapeutic application in human stroke.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Characteristics of the neuroprotective effect of SC51089. (A) Dose-response characteristics in transient MCA occlusion; (B) therapeutic window in transient MCA occlusion (3 days survival); (C) effect in permanent MCA occlusion (1 day survival). (D) The neuroprotective effect of SC51089 is present in female mice. *P < 0.05 from vehicle (analysis of variance and Neuman–Keuls Multiple Comparison test); n = 12/group.
Figure 2
Figure 2
Effect of SC51089 on body weight and neurological function up to 2 weeks after transient MCA occlusion. (A) Body weight; (B) deficit score (modified Bederson scale); (C) latency to fall at the hanging wire test; (D) corner test. *P < 0.05 from vehicle (Mann–Whitney test); n = 12/group.
Figure 3
Figure 3
Effect of SC51089 on injury volume 14 days after transient MCA occlusion. (A) Infarct volume; (B) volume of the hemisphere ipsilateral and contralateral to the stroke; *P < 0.05; n = 12/group.
See this image and copyright information in PMC

References

    1. Ahmad AS, Saleem S, Ahmad M, Dore S. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci. 2006;89:265–70. - PubMed
    1. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 2001;56:1015–20. - PubMed
    1. Beaulieu C, Busch E, Rother J, de Crespigny A, Hsia CJ, Moseley ME. Polynitroxyl albumin reduces infarct size in transient focal cerebral ischemia in the rat: potential mechanisms studied by magnetic resonance imaging. J Cereb Blood Flow Metab. 1998;18:1022–1031. - PubMed
    1. Borsello T, Clarke PG, Hirt L, Vercelli A, Repici M, Schorderet DF, Bogousslavsky J, Bonny C. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med. 2003;9:1180–6. - PubMed
    1. Bouet V, Freret T, Toutain J, Divoux D, Boulouard M, Schumann-Bard P. Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol. 2007;203:555–67. - PubMed

Publication types

MeSH terms

LinkOut - more resources